Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saumya Jayakumar

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
NPJ Vaccines|January 12, 2021
Reduced immune responses to hepatitis B primary vaccination in obese individuals with nonalcoholic fatty liver disease (NAFLD)Shivali S Joshi, Rachelle P Davis, Mang M Ma, et al.
The American Journal of Gastroenterology|August 3, 2016
A Rapid Bedside Screen to Predict Unplanned Hospitalization and Death in Outpatients With Cirrhosis: A Prospective Evaluation of the Clinical Frailty ScalePuneeta Tandon, Navdeep Tangri, Lesley Thomas, et al.
Canadian Journal of Surgery. Journal Canadien De Chirurgie|July 5, 2022
Outcomes of liver transplant recipients with high MELD scores: an experience from a Canadian centreMichael S Bleszynski, Subin Punnen, Sameer Desai, et al.
CMAJ Open|June 10, 2017
Hepatitis B virus testing and linkage to care in a Canadian urban tertiary referral centre: a retrospective cohort studyKeith C K Lau, Abdel Aziz Shaheen, Alexander A Aspinall, et al.
Hepatology (Baltimore, Md.)|September 12, 2017
The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trialRohit Loomba, Eric Lawitz, Parvez S Mantry, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 7, 2017
Association Between Obesity and Discordance in Fibrosis Stage Determination by Magnetic Resonance vs Transient Elastography in Patients With Nonalcoholic Liver DiseaseCyrielle Caussy, Jun Chen, Mosab H Alquiraish, et al.
Journal of Hepatology|September 9, 2014
Effects of n-3 fish oil on metabolic and histological parameters in NASH: a double-blind, randomized, placebo-controlled trialCurtis K Argo, James T Patrie, Carolin Lackner, et al.
Journal of Hepatology|October 7, 2018
Longitudinal correlations between MRE, MRI-PDFF, and liver histology in patients with non-alcoholic steatohepatitis: Analysis of data from a phase II trial of selonsertibSaumya Jayakumar, Michael S Middleton, Eric J Lawitz, et al.
Hepatology (Baltimore, Md.)|March 3, 2020
Cilofexor, a Nonsteroidal FXR Agonist, in Patients With Noncirrhotic NASH: A Phase 2 Randomized Controlled TrialKeyur Patel, Stephen A Harrison, Magdy Elkhashab, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 8, 2025
Expert Delphi Consensus on Surrogate Endpoints for Treatment Assessment in Metabolic Dysfunction-associated SteatohepatitisArun J Sanyal, Atsushi Nakajima, Elisabetta Bugianesi, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
NPJ Vaccines|January 12, 2021
Reduced immune responses to hepatitis B primary vaccination in obese individuals with nonalcoholic fatty liver disease (NAFLD)Shivali S Joshi, Rachelle P Davis, Mang M Ma, et al.
The American Journal of Gastroenterology|August 3, 2016
A Rapid Bedside Screen to Predict Unplanned Hospitalization and Death in Outpatients With Cirrhosis: A Prospective Evaluation of the Clinical Frailty ScalePuneeta Tandon, Navdeep Tangri, Lesley Thomas, et al.
Canadian Journal of Surgery. Journal Canadien De Chirurgie|July 5, 2022
Outcomes of liver transplant recipients with high MELD scores: an experience from a Canadian centreMichael S Bleszynski, Subin Punnen, Sameer Desai, et al.
CMAJ Open|June 10, 2017
Hepatitis B virus testing and linkage to care in a Canadian urban tertiary referral centre: a retrospective cohort studyKeith C K Lau, Abdel Aziz Shaheen, Alexander A Aspinall, et al.
Hepatology (Baltimore, Md.)|September 12, 2017
The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trialRohit Loomba, Eric Lawitz, Parvez S Mantry, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 7, 2017
Association Between Obesity and Discordance in Fibrosis Stage Determination by Magnetic Resonance vs Transient Elastography in Patients With Nonalcoholic Liver DiseaseCyrielle Caussy, Jun Chen, Mosab H Alquiraish, et al.
Journal of Hepatology|September 9, 2014
Effects of n-3 fish oil on metabolic and histological parameters in NASH: a double-blind, randomized, placebo-controlled trialCurtis K Argo, James T Patrie, Carolin Lackner, et al.
Journal of Hepatology|October 7, 2018
Longitudinal correlations between MRE, MRI-PDFF, and liver histology in patients with non-alcoholic steatohepatitis: Analysis of data from a phase II trial of selonsertibSaumya Jayakumar, Michael S Middleton, Eric J Lawitz, et al.
Hepatology (Baltimore, Md.)|March 3, 2020
Cilofexor, a Nonsteroidal FXR Agonist, in Patients With Noncirrhotic NASH: A Phase 2 Randomized Controlled TrialKeyur Patel, Stephen A Harrison, Magdy Elkhashab, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 8, 2025
Expert Delphi Consensus on Surrogate Endpoints for Treatment Assessment in Metabolic Dysfunction-associated SteatohepatitisArun J Sanyal, Atsushi Nakajima, Elisabetta Bugianesi, et al.
Pageof 3